{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T05:20:33Z","timestamp":1768627233451,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":4878,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.imbio.2010.05.023","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T04:20:22Z","timestamp":1275711622000},"page":"756-761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells"],"prefix":"10.1016","volume":"215","author":[{"given":"Valentina","family":"Salvi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Bosisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Mitola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvano","family":"Sozzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2010.05.023_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2010.05.023_bib2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2010.05.023_bib3","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2010.05.023_bib4","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.4049\/jimmunol.171.6.3296","article-title":"Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG","volume":"171","author":"Bave","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2010.05.023_bib6","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1189\/jlb.0708401","article-title":"Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo","volume":"84","author":"Bosisio","year":"2008","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.imbio.2010.05.023_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-04-019711","article-title":"Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function","volume":"109","author":"Brogdon","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2010.05.023_bib8","doi-asserted-by":"crossref","first-page":"49417","DOI":"10.1074\/jbc.M207484200","article-title":"Acetylation of interferon regulatory factor-7 by p300\/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding","volume":"277","author":"Caillaud","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2010.05.023_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1525-0016(03)00235-1","article-title":"A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis","volume":"8","author":"Chung","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.imbio.2010.05.023_bib10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib11","doi-asserted-by":"crossref","DOI":"10.3109\/08916930903510914","article-title":"The type I IFN system in rheumatoid arthritis","author":"Conigliaro","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imbio.2010.05.023_bib12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.imbio.2010.05.023_bib13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.102.042903","article-title":"Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin","volume":"304","author":"De Schepper","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.imbio.2010.05.023_bib14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.194.12.1823","article-title":"BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha\/beta induction","volume":"194","author":"Dzionek","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2010.05.023_bib41","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.leu.2405049","article-title":"The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2(V617F)","volume":"22","author":"Guerini","year":"2008","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.imbio.2010.05.023_bib16","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.4049\/jimmunol.0901467","article-title":"Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue","volume":"184","author":"Grabiec","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20070763","article-title":"PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation","volume":"205","author":"Guiducci","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2010.05.023_bib18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2010.05.023_bib19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature03547","article-title":"Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2010.05.023_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2010.05.023_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/qjmed\/91.6.393","article-title":"Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon","volume":"91","author":"Kalkner","year":"1998","journal-title":"Q. J. Med."},{"key":"10.1016\/j.imbio.2010.05.023_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","author":"Kawai","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib23","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1073\/pnas.052702999","article-title":"The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines","volume":"99","author":"Leoni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2010.05.023_bib24","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.1128\/MCB.20.23.8803-8814.2000","article-title":"Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain","volume":"20","author":"Marie","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.imbio.2010.05.023_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.imbio.2010.05.023_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2010.05.023_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1189\/jlb.0603291","article-title":"Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells","volume":"75","author":"Megjugorac","year":"2004","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.imbio.2010.05.023_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2010.05.023_bib29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.imbio.2009.06.002","article-title":"Plasmacytoid dendritic cells in autoimmune diabetes \u2013 potential tools for immunotherapy","volume":"214","author":"Nikolic","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2010.05.023_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2006.09.014","article-title":"Systemic lupus erythematosus: all roads lead to type I interferons","volume":"18","author":"Pascual","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib31","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.4049\/jimmunol.173.6.4171","article-title":"Modulation of renal disease in MRL\/lpr mice by suberoylanilide hydroxamic acid","volume":"173","author":"Reilly","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.imbio.2009.06.016","article-title":"Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells","volume":"214","author":"Riboldi","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2010.05.023_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.1990.tb00144.x","article-title":"Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour","volume":"227","author":"Ronnblom","year":"1990","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.imbio.2010.05.023_bib34","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.imbio.2010.05.023_bib35","doi-asserted-by":"crossref","DOI":"10.3109\/08916930903510872","article-title":"Type I interferons in systemic autoimmunity","author":"Sozzani","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imbio.2010.05.023_bib36","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.161.6.2672","article-title":"Enhanced anti-HIV-1 activity and altered chemotactic potency on NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor","volume":"161","author":"Struyf","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib37","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.4049\/jimmunol.181.9.6563","article-title":"Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils","volume":"181","author":"Tamassia","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.1999.00772.x","article-title":"Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells","volume":"115","author":"Vallin","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib39","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.4049\/jimmunol.163.11.6306","article-title":"Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus","volume":"163","author":"Vallin","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2010.05.023_bib40","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.imbio.2009.06.013","article-title":"Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage","volume":"214","author":"Vermi","year":"2009","journal-title":"Immunobiology"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298510000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298510000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:28:14Z","timestamp":1759249694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298510000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":41,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0171298510000896"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2010.05.023","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2010.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}